Literature DB >> 33930322

Evolving concepts in NAD+ metabolism.

Claudia C S Chini1, Julianna D Zeidler1, Sonu Kashyap1, Gina Warner1, Eduardo Nunes Chini2.   

Abstract

NAD(H) and NADP(H) have traditionally been viewed as co-factors (or co-enzymes) involved in a myriad of oxidation-reduction reactions including the electron transport in the mitochondria. However, NAD pathway metabolites have many other important functions, including roles in signaling pathways, post-translational modifications, epigenetic changes, and regulation of RNA stability and function via NAD-capping of RNA. Non-oxidative reactions ultimately lead to the net catabolism of these nucleotides, indicating that NAD metabolism is an extremely dynamic process. In fact, recent studies have clearly demonstrated that NAD has a half-life in the order of minutes in some tissues. Several evolving concepts on the metabolism, transport, and roles of these NAD pathway metabolites in disease states such as cancer, neurodegeneration, and aging have emerged in just the last few years. In this perspective, we discuss key recent discoveries and changing concepts in NAD metabolism and biology that are reshaping the field. In addition, we will pose some open questions in NAD biology, including why NAD metabolism is so fast and dynamic in some tissues, how NAD and its precursors are transported to cells and organelles, and how NAD metabolism is integrated with inflammation and senescence. Resolving these questions will lead to significant advancements in the field.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NAD pathway metabolites; NAD(+); aging; disease; humans; mitochondria; transport; vitamin B3

Mesh:

Substances:

Year:  2021        PMID: 33930322      PMCID: PMC8172449          DOI: 10.1016/j.cmet.2021.04.003

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   31.373


  79 in total

1.  The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration.

Authors:  Kow Essuman; Daniel W Summers; Yo Sasaki; Xianrong Mao; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Neuron       Date:  2017-03-22       Impact factor: 17.173

2.  CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.

Authors:  Juliana Camacho-Pereira; Mariana G Tarragó; Claudia C S Chini; Veronica Nin; Carlos Escande; Gina M Warner; Amrutesh S Puranik; Renee A Schoon; Joel M Reid; Antonio Galina; Eduardo N Chini
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

3.  Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside.

Authors:  Łukasz Mateuszuk; Roberto Campagna; Barbara Kutryb-Zając; Kamil Kuś; Ewa M Słominska; Ryszard T Smolenski; Stefan Chlopicki
Journal:  Biochem Pharmacol       Date:  2020-05-08       Impact factor: 5.858

Review 4.  Age-related NAD+ decline.

Authors:  Melanie R McReynolds; Karthikeyani Chellappa; Joseph A Baur
Journal:  Exp Gerontol       Date:  2020-02-22       Impact factor: 4.032

5.  NAXE Mutations Disrupt the Cellular NAD(P)HX Repair System and Cause a Lethal Neurometabolic Disorder of Early Childhood.

Authors:  Laura S Kremer; Katharina Danhauser; Diran Herebian; Danijela Petkovic Ramadža; Dorota Piekutowska-Abramczuk; Annette Seibt; Wolfgang Müller-Felber; Tobias B Haack; Rafał Płoski; Klaus Lohmeier; Dominik Schneider; Dirk Klee; Dariusz Rokicki; Ertan Mayatepek; Tim M Strom; Thomas Meitinger; Thomas Klopstock; Ewa Pronicka; Johannes A Mayr; Ivo Baric; Felix Distelmaier; Holger Prokisch
Journal:  Am J Hum Genet       Date:  2016-09-08       Impact factor: 11.025

Review 6.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.

Authors:  Claudio Franceschi; Judith Campisi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-06       Impact factor: 6.053

7.  The NAD+-mediated self-inhibition mechanism of pro-neurodegenerative SARM1.

Authors:  Yuefeng Jiang; Tingting Liu; Chia-Hsueh Lee; Qing Chang; Jing Yang; Zhe Zhang
Journal:  Nature       Date:  2020-10-14       Impact factor: 49.962

8.  Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3.

Authors:  Nahid A Khan; Mari Auranen; Ilse Paetau; Eija Pirinen; Liliya Euro; Saara Forsström; Lotta Pasila; Vidya Velagapudi; Christopher J Carroll; Johan Auwerx; Anu Suomalainen
Journal:  EMBO Mol Med       Date:  2014-06       Impact factor: 12.137

9.  Epistasis-driven identification of SLC25A51 as a regulator of human mitochondrial NAD import.

Authors:  Enrico Girardi; Gennaro Agrimi; Ulrich Goldmann; Giuseppe Fiume; Sabrina Lindinger; Vitaly Sedlyarov; Ismet Srndic; Bettina Gürtl; Benedikt Agerer; Felix Kartnig; Pasquale Scarcia; Maria Antonietta Di Noia; Eva Liñeiro; Manuele Rebsamen; Tabea Wiedmer; Andreas Bergthaler; Luigi Palmieri; Giulio Superti-Furga
Journal:  Nat Commun       Date:  2020-12-01       Impact factor: 14.919

View more
  20 in total

Review 1.  The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.

Authors:  Julianna D Zeidler; Kelly A Hogan; Guillermo Agorrody; Thais R Peclat; Sonu Kashyap; Karina S Kanamori; Lilian Sales Gomez; Delaram Z Mazdeh; Gina M Warner; Katie L Thompson; Claudia C S Chini; Eduardo Nunes Chini
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-09       Impact factor: 4.249

Review 2.  Regulation of NAD+ metabolism in aging and disease.

Authors:  Xiaogang Chu; Raghavan Pillai Raju
Journal:  Metabolism       Date:  2021-10-28       Impact factor: 8.694

3.  Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications.

Authors:  Priyanka Banerjee; Elizabeth A Olmsted-Davis; Anita Deswal; Minh Th Nguyen; Efstratios Koutroumpakis; Nicholas L Palaskas; Steven H Lin; Sivareddy Kotla; Cielito Reyes-Gibby; Sai-Ching J Yeung; Syed Wamique Yusuf; Momoko Yoshimoto; Michihiro Kobayashi; Bing Yu; Keri Schadler; Joerg Herrmann; John P Cooke; Abhishek Jain; Eduardo Chini; Nhat-Tu Le; Jun-Ichi Abe
Journal:  J Cardiovasc Aging       Date:  2022-04-29

4.  Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells.

Authors:  Alessandro Camponeschi; Kathrin Kläsener; Timothy Sundell; Christina Lundqvist; Paul T Manna; Negar Ayoubzadeh; Martina Sundqvist; Katrin Thorarinsdottir; Mariele Gatto; Marcella Visentini; Karin Önnheim; Alaitz Aranburu; Huamei Forsman; Olov Ekwall; Linda Fogelstrand; Inger Gjertsson; Michael Reth; Inga-Lill Mårtensson
Journal:  J Exp Med       Date:  2022-07-12       Impact factor: 17.579

Review 5.  Role of NAD+ and FAD in Ischemic Stroke Pathophysiology: An Epigenetic Nexus and Expanding Therapeutic Repertoire.

Authors:  Parimala Narne; Prakash Babu Phanithi
Journal:  Cell Mol Neurobiol       Date:  2022-09-30       Impact factor: 4.231

6.  NAD kinase promotes Staphylococcus aureus pathogenesis by supporting production of virulence factors and protective enzymes.

Authors:  Clarisse Leseigneur; Laurent Boucontet; Magalie Duchateau; Javier Pizarro-Cerda; Mariette Matondo; Emma Colucci-Guyon; Olivier Dussurget
Journal:  Elife       Date:  2022-06-20       Impact factor: 8.713

Review 7.  Clinical and biochemical footprints of inherited metabolic diseases. VIII. Neoplasias.

Authors:  Teodoro Jerves; Nenad Blau; Carlos R Ferreira
Journal:  Mol Genet Metab       Date:  2022-03-28       Impact factor: 4.204

8.  Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.

Authors:  Jing Wu; Komudi Singh; Amy Lin; Allison M Meadows; Kaiyuan Wu; Vivian Shing; Maximilian Bley; Shahin Hassanzadeh; Rebecca D Huffstutler; Mark S Schmidt; Luz P Blanco; Rong Tian; Charles Brenner; Mehdi Pirooznia; Mariana J Kaplan; Michael N Sack
Journal:  J Clin Invest       Date:  2022-03-01       Impact factor: 19.456

9.  The potential of aging rejuvenation.

Authors:  Ana O'Loghlen
Journal:  Cell Cycle       Date:  2022-01-03       Impact factor: 4.534

10.  Grape Seed Proanthocyanidin Extract Moderated Retinal Pigment Epithelium Cellular Senescence Through NAMPT/SIRT1/NLRP3 Pathway.

Authors:  Wencui Wan; Wei Zhu; Yan Wu; Yang Long; Hongzhuo Liu; Weiwei Wan; Guangming Wan; Jing Yu
Journal:  J Inflamm Res       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.